Multiple sclerosis (MS) is a chronic disease of the nervous system that can lead to muscle weakness, vision loss, and paralysis. It occurs when the immune system attacks the myelin sheath that ...

In the fall of 2002, I woke up in my Christopher Newport University dorm with blinding pain in my temples. The pain was so acute that it caused partial vision loss. I visited four doctors within a ...

What begins as ringing in the ears, dizziness or ear pain might seem like a routine infection, but for some individuals, these symptoms become the first indicators of multiple sclerosis (MS), a ...

Smoldering-associated worsening (SAW) of multiple sclerosis (MS) deserves a broader, more comprehensive approach to diagnosis, treatment, and research that goes beyond neurologists’ understanding of ...

I’ll never forget the day I was diagnosed with multiple sclerosis (MS). It was my 20th birthday. I was sitting in a coffee shop with a close friend, studying for college midterms. I had just pulled an ...

A multicenter phase 3 trial comparing ocrelizumab to fingolimod for children with MS achieved its noninferiority primary ...

BOSTON -- Treatment with teriflunomide (Aubagio), a drug approved for relapsing multiple sclerosis (MS), reduced the risk of a clinical event in people with radiologically isolated syndrome (RIS), the ...

A.J.S. Rayl's article on the possibility of an oral treatment for multiple sclerosis 1 (MS) once again points out the need for new thinking about the causes and treatments for MS. For over 50 years, ...

MS patients have increased risks of developing other autoimmune diseases, necessitating careful treatment planning to balance efficacy and risk. Dimethyl fumarate, anti-CD20 antibodies, and ozanimod ...